TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32336148

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (⩽5 treatment cycles) in the upper limb
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (⩽5 treatment cycles) in the lower limb
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (⩽5 treatment cycles)
Number of subjects: 599
Study: 34260948

Group type: EXPERIMENTAL
Intervention: FHR proteins (FHR-1, FHR-2, FHR-3, FHR-4, FHR-5) and FHL-1 concentrations measured using a targeted mass-spectrometry assay
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control group (N=252)
Number of subjects: 352
Study: 36285406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Naltrexone-bupropion
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: BWL+placebo
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: BWL+naltrexone-bupropion
Number of subjects: 136
Study: 32811701

Group type: EXPERIMENTAL
Intervention: Playful learning interventions (toys, visual and auditory sources)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no additional instruction)
Number of subjects: 100
Study: 32584677

Group type: EXPERIMENTAL
Intervention: AG (nab-paclitaxel with gemcitabine)
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: FFX (FOLFIRINOX)
Number of subjects: 2199
Study: 34533869

Group type: EXPERIMENTAL
Intervention: 60% 1RM
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 75% 1RM (100% workload)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 90% 1RM
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 75% 1RM (50% workload)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Moderate and vigorous intensity exercise
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Regular activity
Number of subjects: 26
Study: 32615892

Group type: EXPERIMENTAL
Intervention: Breathing meditation
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 73

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 73
Study: 36114491

Group type: EXPERIMENTAL
Intervention: Dibutyl phthalate (DBP) exposure
Number of subjects: 16
Study: 32339253

Group type: EXPERIMENTAL
Intervention: Paclitaxel (80 mg/m2 on day 1, 8, and 15) plus everolimus (10 mg daily, arm B)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo (arm A)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Paclitaxel (80 mg/m2) plus everolimus (10 mg daily) in patients with prior taxane use
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo in patients with prior taxane use
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus everolimus
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 36115817

Group type: EXPERIMENTAL
Intervention: Oxaliplatin plus fluoropyrimidine in Group 1
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine in Group 2
Number of subjects: 491

Group type: COMPARATOR
Intervention: Fluoropyrimidine in Group 1
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine with observation in Group 2
Number of subjects: 491
Study: 33206309

Group type: EXPERIMENTAL
Intervention: Systemic therapy (ST) after RT (n = 999)
Number of subjects: 3095

Group type: EXPERIMENTAL
Intervention: Targeted therapy after RT
Number of subjects: 3095

Group type: EXPERIMENTAL
Intervention: Hormone therapy after RT
Number of subjects: 3095

Group type: EXPERIMENTAL
Intervention: Cytotoxic chemotherapy after RT
Number of subjects: 3095

Group type: EXPERIMENTAL
Intervention: Immunotherapy after RT
Number of subjects: 3095

Group type: EXPERIMENTAL
Intervention: Discontinuation of ST after RT
Number of subjects: 3095

Group type: EXPERIMENTAL
Intervention: Nomogram predicting OS
Number of subjects: 3095

Group type: COMPARATOR
Intervention: No ST before or after RT (Control group, n = 2096)
Number of subjects: 3095
Study: 33544562

Group type: EXPERIMENTAL
Intervention: Provider with at least 10 previous insertions
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Younger than 21 years
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Dalit caste
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Husbands not living at home
Number of subjects: 1232
Study: 34791320

Group type: EXPERIMENTAL
Intervention: COMBI
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: VIPP-FI
Number of subjects: 246

Group type: COMPARATOR
Intervention: RVE
Number of subjects: 246

Group type: COMPARATOR
Intervention: AC
Number of subjects: 246
Study: 34948547

Group type: EXPERIMENTAL
Intervention: Kinect exergames
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Wii exergames
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both Kinect and Wii exergames
Number of subjects: 23
Study: 33262584

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy (COT)
Number of subjects: 320
Study: 35387830

Group type: EXPERIMENTAL
Intervention: Encapsulated lyophilised faecal microbiota transplantation (FMT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 34387964

Group type: EXPERIMENTAL
Intervention: Paracetamol + Ibuprofen (PCM + IBU)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Paracetamol (PCM)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Half Strength-Paracetamol + Ibuprofen (HS-PCM + IBU)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Non-opioid analgesics before surgery
Number of subjects: 556

Group type: COMPARATOR
Intervention: Weak opioids before surgery
Number of subjects: 556

Group type: COMPARATOR
Intervention: No analgesics before surgery
Number of subjects: 556
Study: 32774071

Group type: EXPERIMENTAL
Intervention: TACE/HAIC + S‐1
Number of subjects: 115

Group type: COMPARATOR
Intervention: TACE/HAIC
Number of subjects: 115
Study: 36438254

Group type: EXPERIMENTAL
Intervention: Blood-based HIV self-testing
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral HIV self-testing
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Choice arm
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard-of-care (SOC) arm
Number of subjects: 24
Study: 34211410

Group type: EXPERIMENTAL
Intervention: Mangosteen pericarp extract supplementation
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 32643543

Group type: EXPERIMENTAL
Intervention: Group hypnosis sessions (5 weekly sessions plus audio recordings)
Number of subjects: 12
Study: 36253041

Group type: EXPERIMENTAL
Intervention: Structured rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-structured rehabilitation
Number of subjects: 60
Study: 33840750

Group type: EXPERIMENTAL
Intervention: Shoes + P-FFO
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Shoes + UCBL
Number of subjects: 15

Group type: COMPARATOR
Intervention: Shoes only
Number of subjects: 15
Study: 32302254

Group type: EXPERIMENTAL
Intervention: Authoritative parenting style
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Authoritarian parenting style
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Permissive parenting style
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Neglectful parenting style
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Overall psychological well-being
Number of subjects: 554
Study: 32484228

Group type: EXPERIMENTAL
Intervention: Variants associated with protein levels near IGFBP3 and IGFBP5 genes
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 838
Study: 35833880

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34147854

Group type: EXPERIMENTAL
Intervention: Swimsuit (objectification condition)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sweater (control condition)
Number of subjects: 52
Study: 35134661

Group type: EXPERIMENTAL
Intervention: True RIPC (inflation of upper extremity blood pressure cuff thrice to 30 mmHg above systolic blood pressure for 5 min)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham RIPC (inflation of blood pressure cuff thrice to 30 mmHg for 5 min)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: True RIPC
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham RIPC
Number of subjects: 25
Study: 33902621

Group type: EXPERIMENTAL
Intervention: RPH-104 80 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: RPH-104 160 mg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 34802107

Group type: EXPERIMENTAL
Intervention: Barbed reposition pharyngoplasty (BRP) surgery with preoperative drug-induced sleep endoscopy (DISE) evaluation (Group B)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Barbed reposition pharyngoplasty (BRP) surgery without preoperative drug-induced sleep endoscopy (DISE) evaluation (Group A)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 92
Study: 32881123

Group type: EXPERIMENTAL
Intervention: Autogenous Bone (AB)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Biphasic Bone Graft Material (BBGM)
Number of subjects: 50
Study: 36231972

Group type: EXPERIMENTAL
Intervention: SIT (Sprint Interval Training)
Number of subjects: 37

Group type: COMPARATOR
Intervention: CONT (Control group)
Number of subjects: 37
Study: 32541365

Group type: EXPERIMENTAL
Intervention: AcrySof IQ PanOptix TFNT00 IOL (n=93)
Number of subjects: 182

Group type: COMPARATOR
Intervention: AT LISA tri 839MP IOL (n=89)
Number of subjects: 182
Study: 35686709

Group type: EXPERIMENTAL
Intervention: Accelerated CXL (9 mW/cm2, 10 min)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard CXL (3 mW/cm2, 30 min)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard CXL
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Accelerated CXL
Number of subjects: 27
Study: 33241770

Group type: EXPERIMENTAL
Intervention: [11C]DASB with MCZ
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: [11C]SB207145 with MCZ
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Permutation testing
Number of subjects: 159
Study: 36148821

Group type: EXPERIMENTAL
Intervention: RNS60
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 32914911

Group type: EXPERIMENTAL
Intervention: Fluoroscopy-guided injection
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection
Number of subjects: 210

Group type: COMPARATOR
Intervention: Non-image-guided injection
Number of subjects: 210
Study: 32401335

Group type: EXPERIMENTAL
Intervention: 105° breast shield
Number of subjects: 49

Group type: COMPARATOR
Intervention: 90° breast shield
Number of subjects: 49
Study: 36164278

Group type: EXPERIMENTAL
Intervention: Conceptualizing obesity as a disease
Number of subjects: 365

Group type: COMPARATOR
Intervention: Not conceptualizing obesity as a disease (control)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Endorsing weight as a heuristic for health
Number of subjects: 365
Study: 33393445

Group type: EXPERIMENTAL
Intervention: Lactulose 2 g/day for 2 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35383066

Group type: EXPERIMENTAL
Intervention: 3-month electronic intervention (11 related information pushing and 3 online lectures)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-month electronic intervention
Number of subjects: 0
Study: 34747891

Group type: EXPERIMENTAL
Intervention: Virtual patient simulation training
Number of subjects: 21
Study: 36294490

Group type: EXPERIMENTAL
Intervention: Belt electrode-skeletal muscle electrical stimulation (B-SES) during hemodialysis for 12 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Routine care only for 12 weeks
Number of subjects: 20
Study: 33904784

Group type: EXPERIMENTAL
Intervention: Group acupuncture (AP)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Individual acupuncture (AP)
Number of subjects: 74
Study: 35302631

Group type: EXPERIMENTAL
Intervention: Treatment drugs
Number of subjects: 138235

Group type: EXPERIMENTAL
Intervention: Vaccines
Number of subjects: 138235

Group type: EXPERIMENTAL
Intervention: Other interventions
Number of subjects: 138235
Study: 36287530

Group type: EXPERIMENTAL
Intervention: Permanent irrigation throughout the day (T1) with Plowless cultivation (W1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Irrigation two days after water disappears from the soil (T2) with Plowless cultivation (W1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Permanent soil saturation (T3) with Plowless cultivation (W1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Permanent soil saturation (T3) with stack 60 cm (W2)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Irrigation two days after water disappears from the soil (T2) with stack 60 cm (W2)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Permanent irrigation throughout the day (T1) with stack 80 cm (W3)
Number of subjects: 3
Study: 33957337

Group type: EXPERIMENTAL
Intervention: Topical estradiol (2 mg)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Belief of receiving estradiol treatment
Number of subjects: 212
Study: 35553373

Group type: EXPERIMENTAL
Intervention: Structured, progressive exercise training (ACE+ exercise group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-exercise control (ACE+ control group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-exercise control (ACE- group)
Number of subjects: 42
Study: 32770402

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE)
Number of subjects: 0
Study: 34627809

Group type: EXPERIMENTAL
Intervention: 0.05% atropine continued treatment
Number of subjects: 350

Group type: COMPARATOR
Intervention: 0.05% atropine washout
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: 0.025% atropine continued treatment
Number of subjects: 350

Group type: COMPARATOR
Intervention: 0.025% atropine washout
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: 0.01% atropine continued treatment
Number of subjects: 350

Group type: COMPARATOR
Intervention: 0.01% atropine washout
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Overall continued treatment
Number of subjects: 350

Group type: COMPARATOR
Intervention: Overall washout
Number of subjects: 350
Study: 32243070

Group type: EXPERIMENTAL
Intervention: Hemodiafiltration (HDF)
Number of subjects: 1115
Study: 32149711

Group type: EXPERIMENTAL
Intervention: Serious smartphone game (Resus Days) for 1 hour before ALS lecture
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (traditional ALS training alone)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Serious smartphone game (Resus Days)
Number of subjects: 105
Study: 36401274

Group type: EXPERIMENTAL
Intervention: SVV-based goal-directed fluid therapy (GDFT) with 3 ml/kg hydroxyethyl starch solution when SVV > 15% for more than 5 min intraoperatively
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional fluid therapy
Number of subjects: 0
Study: 32758205

Group type: EXPERIMENTAL
Intervention: Routine removal of the syndesmotic screw
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: On demand removal of the syndesmotic screw
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Total population for the trial
Number of subjects: 196
Study: 34415450

Group type: EXPERIMENTAL
Intervention: Loss condition
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: CFC‐14 Immediate scale and GRCS dimensions Gambling Expectancies and Interpretative Bias
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Cognitions related to gambling
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Gambling severity
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Nonchasers and chasers
Number of subjects: 255
Study: 34585377

Group type: EXPERIMENTAL
Intervention: Intervention (trained facilitators making three visits over six months)
Number of subjects: 14633

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 14633
Study: 32916308

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CRT) with pembrolizumab
Number of subjects: 40
Study: 36430060

Group type: EXPERIMENTAL
Intervention: Multidomain intervention for dormitory environment and roommate behaviour (3 months)
Number of subjects: 364

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 364
Study: 34953042

Group type: EXPERIMENTAL
Intervention: Clofarabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard induction chemotherapy
Number of subjects: 0
Study: 33036027

Group type: EXPERIMENTAL
Intervention: Cardiac surgery in patients with pre‐ICH
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Postoperative management in patients with pre‐ICH
Number of subjects: 363
Study: 35513593

Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 22

Group type: COMPARATOR
Intervention: Clomiphene Citrate
Number of subjects: 22
Study: 34328366

Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy (ERC; using antiarrhythmic drugs or catheter ablation)
Number of subjects: 798

Group type: COMPARATOR
Intervention: Usual care (allowing rhythm control therapy to improve symptoms)
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy (ERC)
Number of subjects: 798
Study: 36287306

Group type: EXPERIMENTAL
Intervention: Berdazimer gel, 10.3%, applied once daily for 12 weeks
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Berdazimer gel, 10.3%
Number of subjects: 891

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 891
Study: 33246896

Group type: EXPERIMENTAL
Intervention: Web-based virtual nursing intervention (experimental group, n = 37)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (n = 38) invited to consult epilepsy-related websites
Number of subjects: 75
Study: 33213406

Group type: EXPERIMENTAL
Intervention: Maternal nutrition education and child spacing interventions
Number of subjects: 422
Study: 35246028

Group type: EXPERIMENTAL
Intervention: Aspirin group (n=11)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: DAPT group (n=17)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (Aspirin and DAPT)
Number of subjects: 28
Study: 32165270

Group type: EXPERIMENTAL
Intervention: Food sensory imagery condition (imagining taste, smell, and texture of palatable foods)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control condition (sensory imagery task for non-food-related activities)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Food sensory imagery intervention
Number of subjects: 171
Study: 35770120

Group type: EXPERIMENTAL
Intervention: Norepinephrine therapy (0.050.5 μg∗kg‐1/min)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional treatment (115 μg/kg∗min dopamine)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Norepinephrine therapy
Number of subjects: 86
Study: 32530836

Group type: EXPERIMENTAL
Intervention: Comic and video
Number of subjects: 57

Group type: COMPARATOR
Intervention: Comic only
Number of subjects: 57
Study: 34957632

Group type: EXPERIMENTAL
Intervention: Exercise in humid heat (40°C, 52% relative humidity)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Hot water immersion (TWI; 36.6°C, thermoneutral)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sauna (55°C, 52% relative humidity)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Heat stress in 40°C water
Number of subjects: 13
Study: 33431380

Group type: EXPERIMENTAL
Intervention: Person-centred e-health platform (Target-D)
Number of subjects: 1868

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1868
Study: 32795562

Group type: EXPERIMENTAL
Intervention: Dual-task training (20 sessions, 1 hour each, twice a week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Single-task training (20 sessions, 1 hour each, twice a week)
Number of subjects: 40
Study: 35774272

Group type: EXPERIMENTAL
Intervention: Dynamic and static shoulder joint brace
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34670042

Group type: EXPERIMENTAL
Intervention: 1200 mg lanifibranor
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: 800 mg lanifibranor
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study: 32428341

Group type: EXPERIMENTAL
Intervention: Affective messaging
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Instrumental messaging
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Self-regulation messaging
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control (nutrition information)
Number of subjects: 116
Study: 36472870

Group type: EXPERIMENTAL
Intervention: Problem-solving treatment (PST)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Health education (control)
Number of subjects: 511
Study: 33627215

Group type: EXPERIMENTAL
Intervention: DPMAS
Number of subjects: 36

Group type: COMPARATOR
Intervention: PE
Number of subjects: 36
Study: 34328623

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 35941584

Group type: EXPERIMENTAL
Intervention: Canagliflozin treatment for 24 weeks
Number of subjects: 129

Group type: COMPARATOR
Intervention: Glimepiride treatment for 24 weeks
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Canagliflozin treatment
Number of subjects: 129
Study: 33236103

Group type: EXPERIMENTAL
Intervention: Dual-release hydrocortisone (DR-HC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: TID-hydrocortisone (TID-HC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both treatments (DR-HC and TID-HC)
Number of subjects: 50
Study: 32912140

Group type: EXPERIMENTAL
Intervention: Adherence to WHO guidelines for antibiotic treatment
Number of subjects: 1564

Group type: EXPERIMENTAL
Intervention: Larger facility size
Number of subjects: 1564

Group type: EXPERIMENTAL
Intervention: Inborn infants
Number of subjects: 1564

Group type: EXPERIMENTAL
Intervention: Dis-advantaged caste families
Number of subjects: 1564

Group type: EXPERIMENTAL
Intervention: Clinical presentation of lethargy or tachypnoea
Number of subjects: 1564

Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 1564
Study: 34284771

Group type: EXPERIMENTAL
Intervention: Textbook study
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Face-to-face seminar
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Video tutorial via online platform
Number of subjects: 67